Results 191 to 200 of about 71,769 (253)

Advanced Thymoma and Advanced Thymic Carcinoma Treatment Practices in 2018–2022: A Nationwide Analysis in Japan

Thoracic Cancer, Volume 17, Issue 15, August 2026.
In the field of rare diseases, where high‐quality evidence remains limited, this study demonstrated how controversial treatment practices are managed in real‐world settings on a nationwide scale. The proportion of anthracycline‐based chemotherapy for stage IV thymoma increased from 50.0% in 2018 to 77.8% in 2022.
Junichi Ishigaki, Ryoko Rikitake, Hidenori Kage, Takahiro Higashi   +3 more
wiley   +1 more source

Chemotherapy-Induced Toxicities in Pediatric Cancer Patients: A Cross-Sectional Survey Using a Child- and Caregiver-Reported Outcome Tool in Tanzania. [PDF]

Drug Healthc Patient Saf
Katabalo DM, Njile E, Kidenya BR, Liwa AC, Schroeder K.   +4 more
europepmc   +1 more source

No association between temozolomide maintenance and survival after first‐line treatment in primary CNS lymphoma

HemaSphere, Volume 10, Issue 8, August 2026.
Nashif Chowdhury, Jenni Niemi, Haris Babačić, Hanna‐Maija Rantakylö, Ingrid Glimelius, Mats Jerkeman, Mats Hellström   +6 more
wiley   +1 more source

B-Lymphoblastic Leukemia With Isolated Central Nervous System Relapse Mimicking a Vestibular Schwannoma. [PDF]

Clin Case Rep
Ng JY, Lalloo ST, Milliken S, Polizzotto MN.   +3 more
europepmc   +1 more source

Refractory ultra-high-risk Choriocarcinoma achieving complete response to intensive multi-agent and intrathecal chemotherapy and anti-PD-L1 therapy. [PDF]

Gynecol Oncol Rep
Venegas L, Grant B, Veneziani AC, Lheureux S, Deljoomanesh S, Millar BA, Bouchard-Fortier G, Jivraj N, Bowering V, Pulman K, Oza AM.   +10 more
europepmc   +1 more source

HIV-associated lymphoproliferative disorders: Single-center experience. [PDF]

Medicine (Baltimore)
Demirtas D, Toptas T, Yilmaz AF, Erturk Sengel B, Yuksel T, Kokkaya YE, Candan O, Yanik AM, Salim S, Ulukoylu Menguc M, Arikan F, Atagunduz I, Korten V, Tuglular AT.   +13 more
europepmc   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vincristine revisited

Critical Reviews in Oncology/Hematology, 1999
Item does not contain ...
Gidding, C.E.M., Kellie, S.J., Kamps, W.A., Graaf, S.S.N. de   +3 more
openaire   +3 more sources

Overdosage with vincristine

The Journal of Pediatrics, 1976
Five patients received overdoses of vincristine ranging from 3.5 to 32 mg. Neurotoxicity accounted for most of the complications observed. Peripheral neuropathies, cranial nerve palsies, paralytic ileus, atony of the bladder, hypertension, hypotension, seizures, inappropriate ADH secretion, and severe bone marrow depression were all encountered.
I A, Kaufman, F H, Kung, H M, Koenig, S T, Giammona   +3 more
openaire   +2 more sources